Heron Therapeutics HRTX
NASDAQ HRTX
$0.35 -0.01 (-2.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Cash & Current Investments (2010 - 2026)

Updated

Heron Therapeutics' Cash & Current Investments was $42.66 million in Q2 2026, up 5.0% from $40.63 million a year earlier but down 4.7% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Heron Therapeutics came in at $46.63 million, down 21.3% from FY2024.

  • Cash & Current Investments has now declined for six consecutive years, with a five-year compound annual growth rate of -25.9% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $59.28 million in FY2024 (-26.3%), $80.41 million in FY2023 (-5.2%), $84.85 million in FY2022 (-46.2%) and $157.58 million in FY2021 (-24.4%).
  • Quarterly Cash & Current Investments has moved between $33.24 million (Q2 2023) and $202.82 million (Q3 2021) over five years.
  • Compared with a year earlier, Cash & Current Investments was higher in 1 of the last eight quarters, with an average decline of 19.2%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q2 2024 (growth of 102.6%); the worst was Q2 2022 (a decline of 67.6%).
  • Per Business Quant data, HRTX's Cash & Current Investments in the three quarters before Q2 2026 was $44.78 million (Q1 2026), $46.63 million (Q4 2025) and $55.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Heron Therapeutics 66.45 Mn -123.12 Mn 26.09 Mn 42.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.66 Mn
Mar 31, 2026 44.78 Mn
Dec 31, 2025 46.63 Mn
Sep 30, 2025 55.49 Mn
Jun 30, 2025 40.63 Mn
Mar 31, 2025 50.68 Mn
Dec 31, 2024 59.28 Mn
Sep 30, 2024 70.89 Mn
Jun 30, 2024 67.35 Mn
Mar 31, 2024 71.52 Mn
Dec 31, 2023 80.41 Mn
Sep 30, 2023 77.41 Mn
Jun 30, 2023 33.24 Mn
Mar 31, 2023 60.02 Mn
Dec 31, 2022 84.85 Mn
Sep 30, 2022 121.75 Mn
Jun 30, 2022 83.54 Mn
Mar 31, 2022 111.91 Mn
Dec 31, 2021 157.58 Mn
Sep 30, 2021 202.82 Mn
API Access

Heron Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=HRTX&period=max&api_key=YOUR_API_KEY